BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38198357)

  • 21. Endothelial Cell-Derived SO
    Liu X; Zhang S; Wang X; Wang Y; Song J; Sun C; Chen G; Yang G; Tao Y; Hu Y; Bu D; Huang Y; Du J; Jin H
    Oxid Med Cell Longev; 2021; 2021():5577634. PubMed ID: 33953829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia/15-HETE in pulmonary endothelial cells.
    Liu Y; Zhang H; Yan L; Du W; Zhang M; Chen H; Zhang L; Li G; Li J; Dong Y; Zhu D
    J Mol Cell Cardiol; 2018 Aug; 121():36-50. PubMed ID: 29913136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension.
    Liao J; Xie SS; Deng Y; Wu DD; Meng H; Lan WF; Dai P
    Microvasc Res; 2023 Mar; 146():104471. PubMed ID: 36566948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells.
    Yu L; Hales CA
    J Vasc Res; 2011; 48(6):465-75. PubMed ID: 21691120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial uncoupling protein 2 regulates mitophagy and pulmonary hypertension during intermittent hypoxia.
    Haslip M; Dostanic I; Huang Y; Zhang Y; Russell KS; Jurczak MJ; Mannam P; Giordano F; Erzurum SC; Lee PJ
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1166-78. PubMed ID: 25814675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
    Zhou X; Jiang Y; Wang Y; Fan L; Zhu Y; Chen Y; Wang Y; Zhu Y; Wang H; Pan Z; Li Z; Zhu X; Ren R; Ge Z; Lai D; Lai EY; Chen T; Wang K; Liang P; Qin L; Liu C; Qiu C; Simons M; Yu L
    Circ Res; 2023 Sep; 133(6):508-531. PubMed ID: 37589160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.
    Wyman AE; Noor Z; Fishelevich R; Lockatell V; Shah NG; Todd NW; Atamas SP
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L945-L958. PubMed ID: 28385812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
    Bao C; He Q; Wang H; Sun Y; Xu Y; Pan Y; Hu Y; Zheng S; Liang S; Luo A; Nahar T; Chen J; Tang H; Han Y
    Oxid Med Cell Longev; 2022; 2022():2782429. PubMed ID: 35757500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
    Hennigs JK; Cao A; Li CG; Shi M; Mienert J; Miyagawa K; Körbelin J; Marciano DP; Chen PI; Roughley M; Elliott MV; Harper RL; Bill MA; Chappell J; Moonen JR; Diebold I; Wang L; Snyder MP; Rabinovitch M
    Circ Res; 2021 Feb; 128(3):401-418. PubMed ID: 33322916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling.
    Yoshida T; Nagaoka T; Nagata Y; Suzuki Y; Tsutsumi T; Kuriyama S; Watanabe J; Togo S; Takahashi F; Matsushita M; Joki Y; Konishi H; Nunomura S; Izuhara K; Conway SJ; Takahashi K
    Respirology; 2022 Jul; 27(7):529-538. PubMed ID: 35318760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients.
    Quarck R; Wynants M; Ronisz A; Sepulveda MR; Wuytack F; Van Raemdonck D; Meyns B; Delcroix M
    Respir Res; 2012 Mar; 13(1):27. PubMed ID: 22452949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STING Contributes to Pulmonary Hypertension by Targeting the Interferon and BMPR2 Signaling through Regulating F2RL3.
    Deng L; Cao C; Cai Z; Wang Z; Leng B; Chen Z; Kong F; Zhou Z; He J; Nie X; Bian JS
    Am J Respir Cell Mol Biol; 2024 Jun; ():. PubMed ID: 38864771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apple polyphenol relieves hypoxia-induced pulmonary arterial hypertension via pulmonary endothelium protection and smooth muscle relaxation: In vivo and in vitro studies.
    Hua C; Zhao J; Wang H; Chen F; Meng H; Chen L; Zhang Q; Yan J; Yuan L
    Biomed Pharmacother; 2018 Nov; 107():937-944. PubMed ID: 30257406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB).
    Li Y; Liu S; Zhang Y; Gao Q; Sun W; Fu L; Cao J
    Cardiovasc Pathol; 2018; 37():8-14. PubMed ID: 30172777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
    Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia.
    Miao H; Hui H; Fan W; Lin Y; Li H; Li D; Luo M; Qiu F; Jiang B; Zhang Y
    Biomed Pharmacother; 2024 Mar; 172():116303. PubMed ID: 38377738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.